| Style | Citing Format |
|---|---|
| MLA | Firooziyan S, et al.. "Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024)." Journal of Arthropod-Borne Diseases, vol. 19, no. 2, 2025, pp. 173-182. |
| APA | Firooziyan S, Enayati A, Rikhtegar E, Asgarian TS, Sedaghat MM (2025). Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024). Journal of Arthropod-Borne Diseases, 19(2), 173-182. |
| Chicago | Firooziyan S, Enayati A, Rikhtegar E, Asgarian TS, Sedaghat MM. "Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024)." Journal of Arthropod-Borne Diseases 19, no. 2 (2025): 173-182. |
| Harvard | Firooziyan S et al. (2025) 'Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024)', Journal of Arthropod-Borne Diseases, 19(2), pp. 173-182. |
| Vancouver | Firooziyan S, Enayati A, Rikhtegar E, Asgarian TS, Sedaghat MM. Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024). Journal of Arthropod-Borne Diseases. 2025;19(2):173-182. |
| BibTex | @article{ author = {Firooziyan S and Enayati A and Rikhtegar E and Asgarian TS and Sedaghat MM}, title = {Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024)}, journal = {Journal of Arthropod-Borne Diseases}, volume = {19}, number = {2}, pages = {173-182}, year = {2025} } |
| RIS | TY - JOUR AU - Firooziyan S AU - Enayati A AU - Rikhtegar E AU - Asgarian TS AU - Sedaghat MM TI - Prevalence and Susceptibility Status of Body Louse (Pediculus Humanus Humanus) (Anoplura: Pediculidae) to Deltamethrin in Urmia City, Iran (2024) JO - Journal of Arthropod-Borne Diseases VL - 19 IS - 2 SP - 173 EP - 182 PY - 2025 ER - |